81
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin

, , , , , , , , & show all
Pages 2705-2719 | Published online: 22 May 2015

References

  • LingXHeYZhangGZhouYYanBIncreased P-glycoprotein expression in mitochondria is related to acquired multidrug resistance in human hepatoma cells depleted of mitochondrial DNAInt J Oncol201240110911821887461
  • LiuZLHiranoTTanakaSOnadaKOkaKPersistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cellsJ Pharm Pharmacol200355111531153714713364
  • LiuYLiBHSunXMLinAHWangDBEffect of selenium on the interaction between daunorubicin and cardiac myosinBiol Trace Elem Res20121471–324024522190261
  • GewirtzDAA critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicinBiochem Pharmacol199957772774110075079
  • FanLLiFZhangHCo-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistanceBiomaterials201031215634564220430433
  • XuWLShenHLAoZFCombination of tetrandrine as a potential-reversing agent with daunorubicin, etoposide and cytarabine for the treatment of refractory and relapsed acute myelogenous leukemiaLeuk Res200630440741316219352
  • ChenBChengJShenMMagnetic nanoparticle of Fe3O4 and 5-bromotetrandrin interact synergistically to induce apoptosis by dauno-rubicin in leukemia cellsInt J Nanomedicine20094657119421371
  • WangFZhangWGuoLGambogic acid suppresses hypoxia-induced hypoxia-inducible factor-1α/vascular endothelial growth factor expression via inhibiting phosphatidylinositol 3-kinase/Akt/mammalian target protein of rapamycin pathway in multiple myeloma cellsCancer Sci201410581063107024890366
  • ChenYBathulaSRYangQHuangLTargeted nanoparticles deliver siRNA to melanomaJ Invest Dermatol2010130122790279820686495
  • Van de VenHVermeerschMMatheeussenAPLGA nano-particles loaded with the antileishmanial saponin β-aescin: factor influence study and in vitro efficacy evaluationInt J Pharm2011420112213221864661
  • ZhouJPatelTRFuMBertramJPSaltzmanWMOcta-functional PLGA nanoparticles for targeted and efficient siRNA delivery to tumorsBiomaterials201233258359122014944
  • BertramJPWilliamsCARobinsonRSegalSSFlynnNTLavikEBIntravenous hemostat: nanotechnology to halt bleedingSci Transl Med200911111ra22
  • BertramJPRauchMFChangKLavikEBUsing polymer chemistry to modulate the delivery of neurotrophic factors from degradable microspheres: delivery of BDNFPharm Res2010271829119921405
  • BertramJPJaySMHynesSRRobinsonRCriscioneJMLavikEBFunctionalized poly(lactic-co-glycolic acid) enhances drug delivery and provides chemical moieties for surface engineering while preserving biocompatibilityActa Biomater2009582860287119433141
  • FahmyTMSamsteinRMHarnessCCMark SaltzmanWSurface modification of biodegradable polyesters with fatty acid conjugates for improved drug targetingBiomaterials200526285727573615878378
  • KeeganMEFalconeJLLeungTCSaltzmanWMBiodegradable microspheres with enhanced capacity for covalently bound surface ligandsMacromolecules2004372697799784
  • ArnoldLJDaganAGutheilJKaplanNOAntineoplastic activity of poly(L-lysine) with some ascites tumor cellsProc Natl Acad Sci USA197976732463250291000
  • MislickKABaldeschwielerJDEvidence for the role of proteoglycans in cation-mediated gene transferProc Natl Acad Sci U S A1996932212349123548901584
  • LiuPYuHSunYZhuMDuanYA mPEG-PLGA-b-PLL copo-lymer carrier for adriamycin and siRNA deliveryBiomaterials201233174403441222436800
  • LiuJQiuZWangSZhouLZhangSA modified double-emulsion method for the preparation of daunorubicin-loaded polymeric nano-particle with enhanced in vitro anti-tumor activityBiomed Mater20105606500220924138
  • SahanaDKMittalGBhardwajVKumarMNPLGA nanoparticles for oral delivery of hydrophobic drugs: influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drugJ Pharm Sci20089741530154217722098
  • BarichelloJMMorishitaMTakayamaKNagaiTEncapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nano-precipitation methodDrug Dev Ind Pharm199925447147610194602
  • LoCTVan TasselPRSaltzmanWMPoly(lactide-co-glycolide) nanoparticle assembly for highly efficient delivery of potent therapeutic agents from medical devicesBiomaterials201031133631364220149428
  • AnandPNairHBSungBDesign of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivoBiochem Phar-macol2010793330338
  • ZambauxMFBonneauxFGrefRInfluence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion methodJ Control Release1998501–331409685870
  • RoscaIDWatariFUoMMicroparticle formation and its mechanism in single and double emulsion solvent evaporationJ Control Release200499227128015380636
  • MurakamiHKobayashiMTakeuchiHKawashimaYPreparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion methodInt J Pharm1999187214315210502620
  • SongXZhaoYWuWPLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: systematic study of particle size and drug entrapment efficiencyInt J Pharm20083501–232032917913411
  • SongXZhaoYHouSDual agents loaded PLGA nanoparticles: systematic study of particle size and drug entrapment efficiencyEur J Pharm Biopharm200869244545318374554
  • KondoKNoguchiMMukaiKTransferrin receptor expression in adenocarcinoma of the lung as a histopathologic indicator of prognosisChest1990976136713712189695
  • WhitneyJFClarkJMGriffinTWGautamSLeslieKOTransferrin receptor expression in nonsmall cell lung cancer. Histopathologic and clinical correlatesCancer199576120258630872
  • PrutkiMPoljak-BlaziMJakopovicMTomasDStipancicIZarkovicNAltered iron metabolism, transferrin receptor 1 and ferritin in patients with colon cancerCancer Lett2006238218819616111806
  • SciotRPatersonACvan EykenPCalleaFKewMCDesmetVJTransferrin receptor expression in human hepatocellular carcinoma: an immunohistochemical study of 34 casesHistopathology198812153632836292
  • RyschichEHusztyGKnaebelHPHartelMBüchlerMWSchmidtJTransferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreasEur J Cancer20044091418142215177502
  • WalkerRADaySJTransferrin receptor expression in non-malignant and malignant human breast tissueJ Pathol198614832172243009766
  • LloydJMO’DowdTDriverMTeeDEDemonstration of an epitope of the transferrin receptor in human cervical epithelium – a potentially useful cell markerJ Clin Pathol19843721311356198338
  • SeymourGJWalshMDLavinMFStruttonGGardinerRATransfer-rin receptor expression by human bladder transitional cell carcinomasUrol Res19871563413443324443
  • TomitaYNishiyamaTSatoSFujiwaraMExpression of transferrin receptor on transitional cell cancerHinyokika Kiyo19913711116 Japanese2011963
  • GatterKCBrownGTrowbridgeISWoolstonREMasonDYTransferrin receptors in human tissues: their distribution and possible clinical relevanceJ Clin Pathol19833655395456302135
  • PileriSGobbiMRivanoMTMartinelliGImmunohistological study of transferrin receptor expression in non-Hodgkin’s lymphomaBr J Haematol19845835015086093847
  • MedeirosLJPickerLJHorningSJWarnkeRATransferrin receptor expression by non-Hodgkin’s lymphomas. Correlation with morpho-logic grade and survivalCancer1988619184418513355978
  • BarnettDWilsonGALawrenceACBuckleyGATransferrin receptor expression in the leukaemias and lymphoproliferative disordersClin Lab Haematol1987943613703442972
  • HabeshawJAListerTAStansfeldAGGreavesMFCorrelation of transferrin receptor expression with histological class and outcome in non-Hodgkin lymphomaLancet1983183234985016131211
  • RechtLDGriffinTWRasoVSalimiARPotent cytotoxicity of an antihuman transferrin receptor-ricin A-chain immunotoxin on human glioma cells in vitroCancer Res19905020669667002208135
  • SoyerHPSmolleJTorneRKerlHTransferrin receptor expression in normal skin and in various cutaneous tumorsJ Cutan Pathol1987141153549812
  • LiXXuYChenGWeiPPingQPLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studiesDrug Dev Ind Pharm200834110711518214762
  • LiXDingLXuYWangYPingQTargeted delivery of doxoru-bicin using stealth liposomes modified with transferrinInt J Pharm20093731–211612319429296
  • AhnCHChaeSYBaeYHKimSWSynthesis of biodegradable multi-block copolymers of poly(L-lysine) and poly(ethylene glycol) as a non-viral gene carrierJ Control Release200497356757415212887
  • LavikEBHrkachJSLotanNNazarovRLangerRA simple synthetic route to the formation of a block copolymer of poly(lactic-co-glycolic acid) and polylysine for the fabrication of functionalized, degradable structures for biomedical applicationsJ Biomed Mater Res200158329129411319743
  • WangYLiXWangLXuYChengXWeiPFormulation and pharmacokinetic evaluation of a paclitaxel nanosuspension for intravenous deliveryInt J Nanomedicine201161497150721796250
  • DengCChenXYuHSunJLuTJingXA biodegradable triblock copolymer poly(ethylene glycol)-b-poly(L-lactide)-b-poly(L-lysine): synthesis, self-assembly, and RGD peptide modificationPolymer2007481139149
  • TakenagaMYamaguchiYKitagawaAOptimum formulation for sustained-release insulinInt J Pharm20042711–2859415129976
  • Cohen-SelaEChornyMKoroukhovNDanenbergHDGolombGA new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticlesJ Control Release20091332909518848962
  • Mora-HuertasCEFessiHElaissariAPolymer-based nanocapsules for drug deliveryInt J Pharm20103851–211314219825408
  • Galindo-RodriguezSAllémannEFessiHDoelkerEPhysicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methodsPharm Res20042181428143915359578
  • NandiAKhakharDVMehraACoalescence in surfactant-stabilized emulsions subjected to shear flowLangmuir200117926472655
  • TeschSSchubertHInfluence of increasing viscosity of the aqueous phase on the short-term stability of protein stabilized emulsionsJ Food Eng2002523305312
  • BudhianASiegelSJWineyKIHaloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug contentInt J Pharm2007336236737517207944
  • MainardesRMEvangelistaRCPLGA nanoparticles containing praziquantel: effect of formulation variables on size distributionInt J Pharm20052901–213714415664139
  • ChungNOLeeMKLeeJMechanism of freeze-drying drug nano-suspensionsInt J Pharm20124371–2425022877696
  • BeirowskiJInghelbrechtSArienAGieselerHFreeze-drying of nanosuspensions, 1: freezing rate versus formulation design as critical factors to preserve the original particle size distributionJ Pharm Sci201110051958196821374626
  • DubernetCThermoanalysis of microspheresThermochim Acta1995248259269